Knowledge Distillery

Filter the news according their assigned tags.
| Cross-sectional case-control studies  

Misinformation about COVID-19 vaccination may contribute substantially to vaccine hesitancy and resistance. The objective of this study was to…

more...
| Literature Review  

Coronavirus disease 2019 (COVID-19) is a disease characterized by a profound dysregulation of the innate immune system. This knowledge has emerged…

more...
| Miscellaneous  

The SARS-CoV-2 Omicron with increased fitness is spreading rapidly worldwide. Analysis of cryo-EM structures of the Spike (S) from Omicron reveals…

more...
| Miscellaneous  

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in southern Africa has been characterized by three distinct waves. The first…

more...
| Miscellaneous  

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for a pandemic affecting billions of people worldwide. Apart from the…

more...
| Miscellaneous  

The recent emergence of B.1.1.529, the Omicron variant has raised concerns for escape from protection by vaccines and therapeutic antibodies.

more...
| Miscellaneous  

SARS-CoV-2 Omicron emerged in November 2021 and is rapidly spreading among the human population. While recent reports reveal that the Omicron variant…

more...
| Miscellaneous  

The SARS-CoV-2 omicron variant of concern was identified in South Africa in November, 2021, and was associated with an increase in COVID-19 cases.

more...
| Expert opinion  

Neurological and neuroradiological manifestations in patients with COVID-19 have been extensively reported. Available imaging data are, however, very…

more...
| Interventional study with open label/non-randomised methodology  

Platelets represent a potential therapeutic target for improved clinical outcomes in patients with COVID-19. The objective of this study was to…

more...
| Randomised double-blinded placebo-controlled trial  

There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission of severe acute respiratory syndrome coronavirus 2…

more...
| Randomised double-blinded placebo-controlled trial  

Easy-to-administer anti–SARS-CoV-2 treatments may be used to prevent progression from asymptomatic infection to symptomatic disease and to reduce…

more...